青年酒店网

天天头条：安道麦B: 独立董事对第九届董事会第十八次会议相关事项的独立意见（英文版）

来源：证券之星

                                ADAMA Ltd.

  Independent Opinion on the Relevant Issues of the


(资料图片)

                                    Directors

In accordance with the Company Law of the People’s Republic of China, Rules for

Independent Directors of Listed Companies, and other laws, regulations and

normative documents, as well as the Articles of Association and Independent Director

System, we, as the independent directors of ADAMA Ltd. (hereinafter referred to as

“Company”), give our independent opinions on the relevant proposal of the 18th

Meeting of the 9th Session of the Board of Directors from the standpoint of

independent judgment:

   Officer

    The nomination and deliberation procedures for the Company’s appointment of

    Chief Financial Officer is lawful and valid.

    After reviewing the profile of the nominee, we believe that Ms. Efrat Nagar’s

    educational background, work experience and physical condition can meet the

    requirements of relevant position. We don’t find there is any situation that

    prohibits Ms. Efrat Nagar from being the Chief Financial Officer of the Company.

    Ms. Efrat Nagar has not been subject to any punishment imposed by the China

    Securities Regulatory Commission and the Shenzhen Stock Exchange (“SZSE”)

    and is not a dishonest party subject to enforcement. We are of the opinion that Ms.

    Efrat Nagar meets the relevant requirements for taking the above position of the

    Company.

    We approve the appointment of Ms. Efrat Nagar as the Chief Financial Officer of

    the Company and her remuneration.

The Company"s wholly-owned subsidiary, Adama Agricultural Solutions Ltd.

("Solutions") (directly, or through one or more of its subsidiaries) is contemplating

applying for new credit facilities not exceeding USD 250 million from any of the

overseas subsidiaries of Syngenta Group Co., Ltd., in order to expand the funding

sources of the Company and its subsidiaries, which is normal business operations.

The Transaction conforms to relevant national laws and regulations, as applicable,

and market-oriented principles, and will not influence the independence of the

Company or damage the interests of the Company and its other shareholders. The

decision-making procedures for the Transaction conform to the Company Law, the

Rules of Shenzhen Stock Exchange for the Listing of Stocks, the Articles of

Association of the Company and other laws and regulations. Therefore, we

approved the Transaction.

 (The signature page of Independent Opinions on the Relevant Issues of the 18th

Meeting of the 9th Session of the Board of Directors)

Independent Director Signature:

__________________                                  ___________________

      Ge Ming                                             Xi Zhen

                                                               February 15, 2023

查看原文公告